Incidence and Risk of Post-COVID-19 Thromboembolic Disease and the Impact of Aspirin Prescription; Nationwide Observational Cohort at the US Department of Veteran Affairs
View ORCID ProfileAnna D Ware, Zachary P Veigulis, Peter J Hoover, Terri L Blumke, George N Ioannou, View ORCID ProfileEdward J Boyko, Thomas F Osborne
doi: https://doi.org/10.1101/2024.04.10.24305647
Anna D Ware
1National Center for Collaborative Healthcare Innovation, VA Palo Alto Healthcare System, Palo Alto, CA, USA
Zachary P Veigulis
1National Center for Collaborative Healthcare Innovation, VA Palo Alto Healthcare System, Palo Alto, CA, USA
2Department of Business Analytics, University of Iowa Tippie College of Business, Iowa City, IA, USA
Peter J Hoover
1National Center for Collaborative Healthcare Innovation, VA Palo Alto Healthcare System, Palo Alto, CA, USA
Terri L Blumke
1National Center for Collaborative Healthcare Innovation, VA Palo Alto Healthcare System, Palo Alto, CA, USA
George N Ioannou
4Center of Innovation for Veteran-Centered and Value-Driven Care, Veterans Affairs Puget Sound Healthcare System, Seattle, WA
5Division of Gastroenterology, Department of Medicine, University of Washington, Seattle, WA
Edward J Boyko
6Seattle Epidemiologic Research and Information Center, Veterans Affairs Puget Sound Healthcare System, Seattle, WA
Thomas F Osborne
1National Center for Collaborative Healthcare Innovation, VA Palo Alto Healthcare System, Palo Alto, CA, USA
3Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA
Data Availability
Due to US Department of Veterans Affairs (VA) regulations and our ethics agreements, the analytic data sets used for this study are not permitted to leave the VA firewall without a Data Use Agreement. This limitation is consistent with other studies based on VA data. However, VA data are made freely available to researchers with an approved VA study protocol. For more information, please visit https://www.virec.research.va.gov or contact the VA Information Resource Center at VIReC@va.gov
Posted April 12, 2024.
Incidence and Risk of Post-COVID-19 Thromboembolic Disease and the Impact of Aspirin Prescription; Nationwide Observational Cohort at the US Department of Veteran Affairs
Anna D Ware, Zachary P Veigulis, Peter J Hoover, Terri L Blumke, George N Ioannou, Edward J Boyko, Thomas F Osborne
medRxiv 2024.04.10.24305647; doi: https://doi.org/10.1101/2024.04.10.24305647
Incidence and Risk of Post-COVID-19 Thromboembolic Disease and the Impact of Aspirin Prescription; Nationwide Observational Cohort at the US Department of Veteran Affairs
Anna D Ware, Zachary P Veigulis, Peter J Hoover, Terri L Blumke, George N Ioannou, Edward J Boyko, Thomas F Osborne
medRxiv 2024.04.10.24305647; doi: https://doi.org/10.1101/2024.04.10.24305647
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2941)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12743)
- Forensic Medicine (12)
- Gastroenterology (828)
- Genetic and Genomic Medicine (4583)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2915)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (924)
- Medical Education (425)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4350)
- Nursing (236)
- Nutrition (639)
- Oncology (2268)
- Ophthalmology (646)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1196)
- Primary Care Research (496)
- Public and Global Health (6936)
- Radiology and Imaging (1527)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (488)
- Toxicology (60)
- Transplantation (212)
- Urology (180)